Blythefan, According to ASX releases and my DD:
the company won't require any more cash until it is cash flow positive. Also the plant processes are tried and tested the technical aspects are not a problem.
The company does, just like any other, have execution risk. The mangament is has pretty good experience is REE some having worked in the industry in China.
- Forums
- ASX - By Stock
- LYC
- gone a bit quiet
gone a bit quiet, page-13
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.68 |
Change
-0.070(0.90%) |
Mkt cap ! $7.169B |
Open | High | Low | Value | Volume |
$7.64 | $7.69 | $7.59 | $5.854M | 766.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 8613 | $7.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.69 | 2849 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 3319 | 7.630 |
13 | 16734 | 7.620 |
10 | 17434 | 7.610 |
6 | 6410 | 7.600 |
7 | 16977 | 7.590 |
Price($) | Vol. | No. |
---|---|---|
7.640 | 3363 | 11 |
7.650 | 8665 | 16 |
7.660 | 13575 | 13 |
7.670 | 9734 | 11 |
7.680 | 27049 | 11 |
Last trade - 12.46pm 13/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online